Creative Biolabs has equipped with advanced instruments, fit-for-purpose laboratories, and professional scientists to provide customized, one-stop solutions for non-IgG antibody development. We provide flexible solutions of your choice, and either stand-alone service or integrated project will be well designed to meet every specific demand.
Jüngste Beiträge
- Exosomes: Small Vesicles, Big Impact on LifeIn recent years, the rapid advancements in precision medicine and biotechnology have ushered in unprecedented transformations in cancer treatment. Among these, exosomes, small extracellular vesicles secreted by nearly all mammalian cells, have emerged as a fascinating area of focus. Their unique biological properties and therapeutic potential have placed them at the forefront of cancer...0 Kommentare 0 Anteile 160 Ansichten 0 VorschauPlease log in to like, share and comment!
- In vitro diagnosticsIn vitro diagnostics (IVD) refers to tests performed on samples such as blood, urine, or tissue taken from the human body. These tests are used to detect diseases, conditions, or infections, providing critical information for diagnosis, prognosis, and treatment. Unlike in vivo diagnostics, IVD tests are conducted outside the living organism, often in controlled laboratory environments or...0 Kommentare 0 Anteile 296 Ansichten 0 Vorschau
- β-lactamase Activity AssayA β-lactamase Activity Assay is a laboratory test used to measure the activity of β-lactamase enzymes. These enzymes are produced by certain bacteria and can break down β-lactam antibiotics (like penicillin), rendering them ineffective. This assay is crucial for detecting bacterial resistance to β-lactam antibiotics. Key Components of the β-lactamase Activity...0 Kommentare 0 Anteile 290 Ansichten 0 Vorschau
- The Dark Horse Path of Breast Cancer TreatmentIn the complex race of cancer treatment, the evolution of breast cancer therapy resembles a dynamic battle of "as high as the mountain, the magic rises higher." Every technological breakthrough not only advances patient survival rates but also reveals deeper biological challenges. The history of breast cancer treatment is an ongoing process of combating resistance and searching for new...0 Kommentare 0 Anteile 289 Ansichten 0 Vorschau
- Pharmaceutical Giants Rush to Develop PD-(L)1 Bispecific Antibodies: A New Battlefield in ImmunotherapyIn recent years, immune checkpoint inhibitors (ICIs) have emerged as a significant breakthrough in cancer therapy, reshaping traditional treatment paradigms. PD-1/PD-L1 pathway inhibitors have been widely used across various cancer treatments, demonstrating impressive efficacy. As PD-(L)1 inhibitor therapies continue to mature, pharmaceutical giants have turned their attention to PD-(L)1...0 Kommentare 0 Anteile 305 Ansichten 0 Vorschau
- 0 Kommentare 0 Anteile 116 Ansichten 0 Vorschau
Mehr Artikel
Gesponsert